GMED Globus Medical Inc stock chart & analysis
Conviction 24HealthcareScan · Fri, Nov 6, 2026Globus Medical Inc (GMED) closed at $71.05 (-12.76%) on Nov 6, 2026. Its latest daily candle is a three outside down. Price is below its 50-day and below its 200-day moving average. RSI(14) 39, RS Rating 66, -29.9% from its 52-week high, -18.6% year to date. Sector: Healthcare · Surgical & Medical Instruments & Apparatus.
Financials as of Wed, Sep 30, 2026 · quarterly.
GMED technical analysis
Trend
GMED is in a downtrend: price is below the 50-day, which is below the 200-day moving average. It closed 8.0% below the 50-day ($77.20) and 14.6% below the 200-day ($83.14). ADX(14) at 24 points to a moderate trend. It meets 0 of 8 trend-template criteria.
Momentum
RSI(14) is 39, in the bearish half of its range. MACD crossed below its signal line on the latest session. Its RS Rating of 66 puts its weighted 12-month performance ahead of about 66% of the US market.
Volume and volatility
Volume on the latest session ran 8.5× its 20-day average. It trades about $152.0M a day on average. ATR(14) is $3.65, 5.1% of price — its typical daily range. On-balance volume is trending down. Chaikin Money Flow (-0.14) shows distribution.
Key levels
The 52-week range is $60.36 to $101.40; price is 29.9% below the high and 17.7% above the low. The VWAP anchored at the 52-week high is $82.51, above price.
Performance
GMED returned -9.0% (1 week), -3.1% (1 month), -17.5% (3 months), -8.9% (6 months), +15.5% (1 year), -18.6% (year to date).
About Globus Medical Inc
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
Surgical & Medical Instruments & Apparatus · Listed 2012 · 6,000 employees
Recent news
- GLOBUS MEDICAL INC: Earnings resultsSEC EDGAR · Thu, Nov 5, 2026
- Globus Medical (GMED) Acquires Neurosurgery Technology To Push Further Into Cranial ProceduresYahoo Finance · Wed, Nov 4, 2026
Congress activity
Disclosed STOCK Act trades in GMED · 6 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Gilbert Cisneros house · D · CA · traded 2026-09-03 | Buy | $1K–$15K | 2026-09-03 | 2026-10-12 | |
Gilbert Cisneros house · D · CA · traded 2026-08-19 | Buy | $15K–$50K | 2026-08-19 | 2026-09-10 | |
 Lisa McClain house · R · MI · traded 2025-06-24 | Sell | $1K–$15K | 2025-06-24 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-07-10 | Sell | $1K–$15K | 2025-07-10 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-06-17 | Buy | $1K–$15K | 2025-06-17 | 2025-08-13 | |
 Josh Gottheimer house · D · NJ · traded 2025-04-09 | Sell | $1K–$15K | 2025-04-09 | 2025-05-14 |
Insider activity
SEC Form 4 transactions in GMED · open-market 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
RHOADS ANN D Director · Class A Common Stock · 2026-11-04 | Sell | 5K | $425K | 2026-11-04 | 2026-11-05 |
ZARRILLI STEPHEN T Director · Class A Common Stock · 2026-08-18 | Exercise | 25K | $1.3M | 2026-08-18 | 2026-08-19 |
ZARRILLI STEPHEN T Director · Stock Option (Right to Buy Class A Common Stock) · 2026-08-18 | Exercise | 25K | — | 2026-08-18 | 2026-08-19 |
ZARRILLI STEPHEN T Director · Class A Common Stock · 2026-08-18 | Sell | 25K | $2.2M | 2026-08-18 | 2026-08-19 |
Davidar David D Director · Class A Common Stock · 2026-07-27 | Gift | 2.5K | — | 2026-07-27 | 2026-07-28 |
Davidar David D Director · Stock Option (Right to Buy Class A Common Stock) · 2026-06-05 | Exercise | 25K | $0 | 2026-06-05 | 2026-06-09 |
Davidar David D Director · Class A Common Stock · 2026-06-05 | Sell | 25K | $2.0M | 2026-06-05 | 2026-06-09 |
Davidar David D Director · Class A Common Stock · 2026-06-05 | Other | — | — | 2026-06-05 | 2026-06-09 |
Davidar David D Director · Class A Common Stock · 2026-06-05 | Exercise | 25K | $657K | 2026-06-05 | 2026-06-09 |
RHOADS ANN D Director · Class A Common Stock · 2026-06-04 | Exercise | 25K | $657K | 2026-06-04 | 2026-06-08 |
SEC filings
EDGAR filings in GMED · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.